QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||
For the quarterly period ended | ||||||||
OR | ||||||||
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||
For the transition period | from ________ to ________ |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) |
(Address of Principal Executive Offices) | (Zip Code) |
No Changes | |||||||||||
(Former name, former address and former fiscal year, if changed since last report) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
☒ | Accelerated filer | ☐ | |||||||||
Non-accelerated filer | ☐ | Smaller reporting company | |||||||||
Emerging growth company |
Class | Outstanding at July 26, 2022 | ||||||||||
Common Stock, $0.01 par value per share | shares |
Page | ||||||||
Part I. FINANCIAL INFORMATION | ||||||||
Item 1. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Part II. OTHER INFORMATION | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 5. | ||||||||
Item 6. | ||||||||
June 30, 2022 | December 31, 2021 | ||||||||||
Assets | (unaudited) | ||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Restricted cash and cash equivalents | |||||||||||
Default funds and margin deposits (including restricted cash and cash equivalents of $ | |||||||||||
Financial investments | |||||||||||
Receivables, net | |||||||||||
Other current assets | |||||||||||
Total current assets | |||||||||||
Property and equipment, net | |||||||||||
Goodwill | |||||||||||
Intangible assets, net | |||||||||||
Operating lease assets | |||||||||||
Other non-current assets | |||||||||||
Total assets | $ | $ | |||||||||
Liabilities | |||||||||||
Current liabilities: | |||||||||||
Accounts payable and accrued expenses | $ | $ | |||||||||
Section 31 fees payable to SEC | |||||||||||
Accrued personnel costs | |||||||||||
Deferred revenue | |||||||||||
Other current liabilities | |||||||||||
Default funds and margin deposits | |||||||||||
Short-term debt | |||||||||||
Total current liabilities | |||||||||||
Long-term debt | |||||||||||
Deferred tax liabilities, net | |||||||||||
Operating lease liabilities | |||||||||||
Other non-current liabilities | |||||||||||
Total liabilities | |||||||||||
Commitments and contingencies | |||||||||||
Equity | |||||||||||
Nasdaq stockholders’ equity: | |||||||||||
Common stock, $ | |||||||||||
Additional paid-in capital | |||||||||||
Common stock in treasury, at cost: | ( | ( | |||||||||
Accumulated other comprehensive loss | ( | ( | |||||||||
Retained earnings | |||||||||||
Total Nasdaq stockholders’ equity | |||||||||||
Noncontrolling interests | |||||||||||
Total equity | |||||||||||
Total liabilities and equity | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||||
Market Technology | $ | $ | $ | $ | |||||||||||||||||||
Investment Intelligence | |||||||||||||||||||||||
Corporate Platforms | |||||||||||||||||||||||
Market Services | |||||||||||||||||||||||
Other revenues | |||||||||||||||||||||||
Total revenues | |||||||||||||||||||||||
Transaction-based expenses: | |||||||||||||||||||||||
Transaction rebates | ( | ( | ( | ( | |||||||||||||||||||
Brokerage, clearance and exchange fees | ( | ( | ( | ( | |||||||||||||||||||
Revenues less transaction-based expenses | |||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Compensation and benefits | |||||||||||||||||||||||
Professional and contract services | |||||||||||||||||||||||
Computer operations and data communications | |||||||||||||||||||||||
Occupancy | |||||||||||||||||||||||
General, administrative and other | |||||||||||||||||||||||
Marketing and advertising | |||||||||||||||||||||||
Depreciation and amortization | |||||||||||||||||||||||
Regulatory | |||||||||||||||||||||||
Merger and strategic initiatives | |||||||||||||||||||||||
Restructuring charges | |||||||||||||||||||||||
Total operating expenses | |||||||||||||||||||||||
Operating income | |||||||||||||||||||||||
Interest income | |||||||||||||||||||||||
Interest expense | ( | ( | ( | ( | |||||||||||||||||||
Net gain on divestiture of business | |||||||||||||||||||||||
Other income | |||||||||||||||||||||||
Net income from unconsolidated investees | |||||||||||||||||||||||
Income before income taxes | |||||||||||||||||||||||
Income tax provision | |||||||||||||||||||||||
Net income | |||||||||||||||||||||||
Net loss attributable to noncontrolling interests | |||||||||||||||||||||||
Net income attributable to Nasdaq | $ | $ | $ | $ | |||||||||||||||||||
Per share information: | |||||||||||||||||||||||
Basic earnings per share | $ | $ | $ | $ | |||||||||||||||||||
Diluted earnings per share | $ | $ | $ | $ | |||||||||||||||||||
Cash dividends declared per common share | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Net income | $ | $ | $ | $ | |||||||||||||||||||
Other comprehensive income (loss): | |||||||||||||||||||||||
Foreign currency translation gains (losses) | ( | ( | ( | ||||||||||||||||||||
Income tax benefit (expense)(1) | ( | ( | ( | ||||||||||||||||||||
Foreign currency translation, net | ( | ( | ( | ||||||||||||||||||||
Comprehensive income | |||||||||||||||||||||||
Comprehensive loss attributable to noncontrolling interests | |||||||||||||||||||||||
Comprehensive income attributable to Nasdaq | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||||||||||||||||||||||||||
Shares | $ | Shares | $ | Shares | $ | Shares | $ | ||||||||||||||||||||||||||||||||||||||||
Common stock | |||||||||||||||||||||||||||||||||||||||||||||||
Additional paid-in capital | |||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | |||||||||||||||||||||||||||||||||||||||||||||||
Share repurchase program | ( | ( | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||
ASR agreement(1) | — | — | — | — | ( | ( | — | — | |||||||||||||||||||||||||||||||||||||||
Share-based compensation | — | ||||||||||||||||||||||||||||||||||||||||||||||
Stock option exercises, net | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Other issuances of common stock, net(2) | — | — | |||||||||||||||||||||||||||||||||||||||||||||
Ending balance | |||||||||||||||||||||||||||||||||||||||||||||||
Common stock in treasury, at cost | |||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Other employee stock activity | — | ( | — | ( | — | ( | — | ( | |||||||||||||||||||||||||||||||||||||||
Ending balance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Accumulated other comprehensive loss | |||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Ending balance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Retained earnings | |||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | |||||||||||||||||||||||||||||||||||||||||||||||
Net income attributable to Nasdaq | |||||||||||||||||||||||||||||||||||||||||||||||
Cash dividends declared per common share | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Ending balance | |||||||||||||||||||||||||||||||||||||||||||||||
Total Nasdaq stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||
Noncontrolling interests | |||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | |||||||||||||||||||||||||||||||||||||||||||||||
Net activity related to noncontrolling interests | — | ( | |||||||||||||||||||||||||||||||||||||||||||||
Ending balance | |||||||||||||||||||||||||||||||||||||||||||||||
Total Equity | $ | $ | $ | $ |
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ | $ | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Depreciation and amortization | |||||||||||
Share-based compensation | |||||||||||
Deferred income taxes | |||||||||||
Extinguishment of debt | |||||||||||
Net gain on divestiture of business | ( | ||||||||||
Net income from unconsolidated investees | ( | ( | |||||||||
Other reconciling items included in net income | |||||||||||
Net change in operating assets and liabilities, net of effects of acquisitions: | |||||||||||
Receivables, net | ( | ||||||||||
Other assets | ( | ||||||||||
Accounts payable and accrued expenses | ( | ||||||||||
Section 31 fees payable to SEC | ( | ||||||||||
Accrued personnel costs | ( | ( | |||||||||
Deferred revenue | |||||||||||
Other liabilities(1) | ( | ( | |||||||||
Net cash provided by operating activities | |||||||||||
Cash flows from investing activities: | |||||||||||
Purchases of securities | ( | ( | |||||||||
Proceeds from sales and redemptions of securities | |||||||||||
Proceeds from divestiture of business, net of cash divested | |||||||||||
Acquisition of businesses, net of cash and cash equivalents acquired | ( | ( | |||||||||
Purchases of property and equipment | ( | ( | |||||||||
Investments related to default funds and margin deposits, net(2) | ( | ( | |||||||||
Other investing activities | ( | ||||||||||
Net cash used in investing activities | ( | ( | |||||||||
Cash flows from financing activities: | |||||||||||
Proceeds from (repayments of) commercial paper, net | ( | ||||||||||
Repayments of borrowings under our credit commitment | ( | ( | |||||||||
Payment of debt extinguishment cost | ( | ||||||||||
Proceeds from issuances of debt, net of issuance costs and utilization of credit commitment | |||||||||||
Repurchases of common stock | ( | ( | |||||||||
ASR agreement | ( | ||||||||||
Dividends paid | ( | ( | |||||||||
Proceeds received from employee stock activity and other issuances | |||||||||||
Payments related to employee shares withheld for taxes | ( | ( | |||||||||
Default funds and margin deposits | ( | ||||||||||
Other financing activities | ( | ||||||||||
Net cash provided by (used in) financing activities | ( | ||||||||||
Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | ( | ( | |||||||||
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents | ( | ||||||||||
Cash and cash equivalents, restricted cash and cash equivalents at beginning of period | |||||||||||
Cash and cash equivalents, restricted cash and cash equivalents at end of period | $ | $ | |||||||||
Reconciliation of Cash, Cash Equivalents and Restricted Cash and Cash Equivalents | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Restricted cash and cash equivalents | |||||||||||
Restricted cash and cash equivalents (default funds and margin deposits) | |||||||||||
Total | $ | $ | |||||||||
Supplemental Disclosure Cash Flow Information | |||||||||||
Interest paid | $ | $ | |||||||||
Income taxes paid, net of refund(1) | $ | $ |
Six Months Ended June 30, 2021 | |||||||||||
As Reported | Adjustment | Adjusted | |||||||||
(in millions) | |||||||||||
Net cash provided by operating activities | $ | $ | $ | ||||||||
Net cash used in investing activities | ( | ( | ( | ||||||||
Net cash used in financing activities | ( | ( | ( | ||||||||
Effect of exchange rate changes on cash, cash equivalents, restricted cash and cash equivalents | ( | ( | ( | ||||||||
Net decrease in cash, cash equivalents, restricted cash and cash equivalents | ( | ( | ( | ||||||||
Cash, cash equivalents, restricted cash and cash equivalents at beginning of period | |||||||||||
Cash, cash equivalents, restricted cash and cash equivalents at end of period | $ | $ | $ | ||||||||
Reconciliation of Cash, Cash Equivalents and Restricted Cash and Cash Equivalents | |||||||||||
Cash and cash equivalents | $ | $ | $ | ||||||||
Restricted cash and cash equivalents | |||||||||||
Restricted cash and cash equivalents (Default funds and margin deposits) | |||||||||||
Total | $ | $ | $ |